Organigram Global Inc. (OGI) vs Sutro Biopharma, Inc. (STRO)
A side-by-side comparison of Organigram Global Inc. and Sutro Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OGI
Organigram Global Inc.
$0.97HealthcareDelayed quote: Oct 6, 2026, 3:04 PM EDT
STRO
Sutro Biopharma, Inc.
$14.62HealthcareDelayed quote: Oct 6, 2026, 3:05 PM EDT
Total return — OGI vs STRO
growth of $100 · dividends reinvested · last 7yOGI -97.0% (-39.4%/yr)STRO -84.5% (-23.4%/yr)STRO compounded faster over this window
Log scale — wide-divergence pair
OGI STRO
OGI vs STRO: by the numbers
- •STRO is the larger company ($141M vs $137M market cap).
- •OGI is profitable (27.54% net margin) while STRO runs a net loss (-395.25%).
- •OGI grew revenue faster over the past five years (29.78% vs 19.13% CAGR).
Metrics side by side
Valuation
| Metric | OGI | STRO |
|---|---|---|
| P/E ratio | 2.18 | N/A |
| P/S ratio | 0.62 | 3.10 |
| P/B ratio | 0.40 | N/A |
| EV / EBITDA | 10.68 | N/A |
Profitability
| Metric | OGI | STRO |
|---|---|---|
| Gross margin | 3.67% | 97.20% |
| Operating margin | -34.07% | -102.41% |
| Net margin | 27.54% | -395.25% |
| ROE | 15.55% | N/A |
| ROIC | -0.98% | -100.04% |
Growth (annualized)
| Metric | OGI | STRO |
|---|---|---|
| Revenue CAGR (5Y) | 29.78% | 19.13% |
| Total return CAGR (5Y) | -36.62% | -39.51% |
Frequently asked
- Which has grown faster, OGI or STRO?
- Over the past five years, OGI grew revenue faster — OGI at a 29.78% CAGR versus STRO at 19.13%.
- Is OGI or STRO more profitable?
- OGI runs the higher net margin — OGI at 27.54% versus STRO at -395.25%.
- How have OGI and STRO total returns compared?
- Over the past 5 years, OGI delivered -36.62% and STRO delivered -39.51% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Organigram Global P/E ratioOrganigram Global ROESutro Biopharma ROEOrganigram Global operating marginSutro Biopharma operating marginOrganigram Global revenue growthSutro Biopharma revenue growthOrganigram Global free cash flowSutro Biopharma free cash flow
Organigram Global & Sutro Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.